|
Volumn 24, Issue 5-7, 2005, Pages 397-400
|
Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3′-C- ethynylcytidine (ECYD)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3' ETHYNYLCYTIDINE;
5 BROMOURACIL DERIVATIVE;
5 IODOURACIL DERIVATIVE;
AZACITIDINE;
AZAURIDINE;
CYTIDINE DERIVATIVE;
NUCLEIC ACID BASE;
UNCLASSIFIED DRUG;
URACIL DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
CHEMICAL MODIFICATION;
CONCENTRATION RESPONSE;
CONFERENCE PAPER;
CONFORMATIONAL TRANSITION;
DRUG POTENCY;
DRUG SYNTHESIS;
EVALUATION;
HUMAN;
HUMAN CELL;
IC 50;
ANTIMETABOLITES;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CHEMISTRY, PHARMACEUTICAL;
CYTIDINE;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
INHIBITORY CONCENTRATION 50;
MODELS, CHEMICAL;
NEOPLASMS;
NUCLEIC ACID CONFORMATION;
URACIL;
URIDINE;
|
EID: 26644462658
PISSN: 15257770
EISSN: 15322335
Source Type: Journal
DOI: 10.1081/NCN-200059821 Document Type: Conference Paper |
Times cited : (5)
|
References (9)
|